UBC Division of Dermatology, Hair Research and Treatment Centre
Vancouver, British Columbia, V6G 1Y6, Canada
NCT Number: NCT00175617
This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.
Looking for future studies?
Notify Me18 year–75 year
Female
Interventional
Phase 2
Vancouver, British Columbia, V6G 1Y6, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.
This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.
Time frame: after 3, 6 and 9 months
University of British Columbia
Other
Efficacy of Therapy With the Anti-androgen Spironolactone Compared to Topical Minoxidil in Female Pattern Hair Loss
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07096323
Female Pattern Hair Loss
Cairo, Egypt
View Trial DetailsNCT04090801
Female Pattern Hair Loss
View Trial DetailsNCT02206802
Alopecia, Female Pattern Hair Loss
Tucson, Arizona, United States
View Trial DetailsNCT01900041
Alopecia, Androgenetic Alopecia (AGA)
Moscow, Russia
View Trial Details